GCT Semiconductor Holding, Inc. (GCTS): Nasdaq/NYSE listing notice — Concord Acquisition Corp III receives NYSE noncompliance notice for fewer than 300 public stockholders

GCT Semiconductor Holding, Inc.

NYSE notice dated Jan 19, 2024; Company has fewer than 300 public stockholders, violating Section 802.01B.
Company has 45 days to submit a business plan to demonstrate how it will regain compliance within 18 months.
No immediate impact on listing; NYSE will continue trading if plan is approved, subject to progress reviews.
Company expects to reach 300 public stockholders upon completion of an initial business combination.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GCT Semiconductor Holding, Inc. received a nyse noncompliance notice notice regarding shareholders (rules 802.01B).

Exchange: nyse
Notice: noncompliance notice
Deficiency: shareholders
Rules: 802.01B

Exact text from the filing

January 19, 2024, Concord Acquisition Corp III (the “Company”) received a notification (the “Notice”) from the New York Stock Exchange (the “NYSE”) informing the Company that, because the number of public stockholders is less than 300, the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires the Company to maintain a minimum of 300 public stockholders on a continuous basis. The Notice specifies that the Company has 45 days to submit a business plan that demonstrates how the Company expects to return to compliance wi

View on SEC.gov

Browse all listing & compliance notices →

GCT Semiconductor Holding, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-006497

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.